Deutsche Bank’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
6CM
OM
Deutsche Bank's APTO Position: Q2 2021 in Review
Deutsche Bank sold out of Aptose Biosciences (APTO) in Q2 2021, closing a stake of 21 shares — an estimated $57K sold.
Deutsche Bank first reported a position in APTO in Q1 2015 and held it in 19 quarters. The position peaked at $687K in Q2 2020. 63 funds tracked by Wall St. Rank hold APTO as of Q2 2021.
- Deutsche Bank reported no remaining Aptose Biosciences position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 21 Aptose Biosciences shares in Q2 2021, an estimated $57K.
- Deutsche Bank first reported a position in Aptose Biosciences in Q1 2015 and held it in 19 quarters.
- Deutsche Bank's Aptose Biosciences position peaked at $687K in Q2 2020.
- 63 funds tracked by Wall St. Rank held Aptose Biosciences as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.